SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (105)10/4/1997 10:13:00 PM
From: Eduardo Canto   of 569
 
John,

I agree with you in that intrarticular HA is probably not expensive. The three shots which would be given weekly should add up to about $300 if I remember correctly. For 6 months worth of relief thats $50/month sounds reasonable to me. Particularly knowing that the cost to the US economy for osteoarthritis is about $55 billion in lost wages, production and direct costs per year, with 16 million Americans affected thats about $3K/yr/patient. It should also go well with insurance companies who are trying to avoid the 225,000 knee replacement surgeries for OA/yr.

Keep an eye on Anika,
E.C.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News